Title of article
Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes Original Research Article
Author/Authors
Naveed Sattar، نويسنده , , Mahesh Perera، نويسنده , , Michael Small، نويسنده , , Mary-Ann Lumsden، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 1999
Pages
2
From page
487
To page
488
Abstract
C-reactive protein concentrations as a marker of inflammation predicts vascular risk and is raised in type-2 diabetes. In a 6-month double-blind placebo controlled trial, a combination of transdermal oestradiol 80 μg with continuous oral norethisterone 1 mg significantly reduced C-reactive protein concentrations in postmenopausal women with type-2 diabetes.
Journal title
The Lancet
Serial Year
1999
Journal title
The Lancet
Record number
549147
Link To Document